The Department of Translational Hematology & Oncology Research conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
More About UsThe Li Lily Wang lab studies how immune checkpoint proteins regulate anti-tumor immune responses.
Learn MoreThe Yogen Saunthararajah lab studies how to selectively target and eliminate cancer cells without harming healthy cells.
Learn MoreThe right combination and order of already-existing drugs show promise as a nontoxic method of treating the aggressive form of cancer.
Cleveland Clinic’s Asfand Yar Cheema, MD, earned SOHO honors for research on GLP-1s and their role in blood cancer progression.
By looking beyond known cancer genes, Cleveland Clinic and St. Jude Children’s Hospital researchers have found a new inherited risk factor for childhood osteosarcoma.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Translational Hematology & Oncology Research.
View Careers